Günther Raab

822 total citations
10 papers, 605 citations indexed

About

Günther Raab is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine. According to data from OpenAlex, Günther Raab has authored 10 papers receiving a total of 605 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Cancer Research and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Günther Raab's work include Cancer Treatment and Pharmacology (7 papers), Breast Cancer Treatment Studies (6 papers) and Breast Lesions and Carcinomas (3 papers). Günther Raab is often cited by papers focused on Cancer Treatment and Pharmacology (7 papers), Breast Cancer Treatment Studies (6 papers) and Breast Lesions and Carcinomas (3 papers). Günther Raab collaborates with scholars based in Germany, Spain and United Kingdom. Günther Raab's co-authors include Holger Eidtmann, Serban Dan Costa, Jens‐Uwe Blohmer, J. Hilfrich, Gϋnter von Minckwitz, Christian Jackisch, M. Kaufmann, W. Eiermann, Ángel Martínez-Agulló and Aňa Lluch and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Annals of Oncology.

In The Last Decade

Günther Raab

10 papers receiving 585 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Günther Raab 465 394 210 87 62 10 605
A.H. Tulusan 452 1.0× 387 1.0× 210 1.0× 96 1.1× 69 1.1× 22 637
G. Raab 483 1.0× 487 1.2× 178 0.8× 30 0.3× 81 1.3× 19 650
Debbie Frye 373 0.8× 396 1.0× 126 0.6× 60 0.7× 101 1.6× 13 556
Frank C. Schell 285 0.6× 345 0.9× 150 0.7× 55 0.6× 62 1.0× 14 502
Maik Hauschild 415 0.9× 402 1.0× 161 0.8× 66 0.8× 111 1.8× 24 593
Meghan Brennan 211 0.5× 161 0.4× 156 0.7× 122 1.4× 70 1.1× 14 393
Charles E. Leonard 392 0.8× 224 0.6× 163 0.8× 134 1.5× 212 3.4× 34 621
I. Raoust 321 0.7× 282 0.7× 164 0.8× 111 1.3× 143 2.3× 22 546
Riccardo Giovanazzi 320 0.7× 201 0.5× 204 1.0× 178 2.0× 48 0.8× 24 583
Emma J. Groen 205 0.4× 243 0.6× 212 1.0× 83 1.0× 65 1.0× 15 485

Countries citing papers authored by Günther Raab

Since Specialization
Citations

This map shows the geographic impact of Günther Raab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Günther Raab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Günther Raab more than expected).

Fields of papers citing papers by Günther Raab

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Günther Raab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Günther Raab. The network helps show where Günther Raab may publish in the future.

Co-authorship network of co-authors of Günther Raab

This figure shows the co-authorship network connecting the top 25 collaborators of Günther Raab. A scholar is included among the top collaborators of Günther Raab based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Günther Raab. Günther Raab is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
2.
Auer, Florian, et al.. (2007). Technical Improvement of pO2 Measurements in Breast Cancer. Strahlentherapie und Onkologie. 183(5). 265–270. 3 indexed citations
3.
Loibl, Sibylle, Gϋnter von Minckwitz, Günther Raab, et al.. (2006). Surgical Procedures After Neoadjuvant Chemotherapy in Operable Breast Cancer: Results of the GEPARDUO Trial. Annals of Surgical Oncology. 13(11). 1434–1442. 66 indexed citations
4.
Minckwitz, Gϋnter von, Jens‐Uwe Blohmer, Andrea Loehr, et al.. (2006). Pegfilgrastim alone or with ciproflaxin significantly reduces febrile neutropenia and hospitalization vs G-CSF alone in breast cancer patients receiving neoadjuvant chemotherapy with docetaxel/doxorubicin/cyclophosphamide (TAC). European Journal of Cancer Supplements. 4(2). 151–152. 2 indexed citations
5.
Gianni, Luca, José Baselga, W. Eiermann, et al.. (2005). Feasibility and Tolerability of Sequential Doxorubicin/Paclitaxel Followed by Cyclophosphamide, Methotrexate, and Fluorouracil and Its Effects on Tumor Response as Preoperative Therapy. Clinical Cancer Research. 11(24). 8715–8721. 126 indexed citations
6.
Minckwitz, Gϋnter von, Jens‐Uwe Blohmer, Alfredo Löhr, et al.. (2005). Primary prophylaxis with 3 weekly pegfilgrastim and ciprofloxacin effectively prevent (febrile) neutropenia and infection during neoadjuvant chemotherapy with docetaxel/doxorubicin/cyclophosphamide (TAC) in breast cancer patients. Journal of Clinical Oncology. 23(16_suppl). 8008–8008. 17 indexed citations
7.
Minckwitz, Gϋnter von, Jens‐Uwe Blohmer, Günther Raab, et al.. (2004). In vivo chemosensitivity-adapted preoperative chemotherapy in patients with early-stage breast cancer: the GEPARTRIO pilot study. Annals of Oncology. 16(1). 56–63. 146 indexed citations
8.
Jackisch, Christian, Gϋnter von Minckwitz, Holger Eidtmann, et al.. (2002). Dose-Dense Biweekly Doxorubicin/Docetaxel Versus Sequential Neoadjuvant Chemotherapy with Doxorubicin/Cyclophosphamide/Docetaxel in Operable Breast Cancer: Second Interim Analysis. Clinical Breast Cancer. 3(4). 276–280. 36 indexed citations
9.
Costa, Serban Dan, G von Minckwitz, Günther Raab, et al.. (1999). The role of docetaxel (Taxotere) in neoadjuvant chemotherapy of breast cancer.. PubMed. 26(3 Suppl 9). 24–31. 33 indexed citations
10.
McFadyen, Iain J., et al.. (1989). Progesterone cream for cyclic breast pain.. BMJ. 298(6678). 931–931. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by A.H. Tulusan Breakdown of academic impact, for papers by G. Raab Breakdown of academic impact, for papers by Debbie Frye Breakdown of academic impact, for papers by Frank C. Schell Breakdown of academic impact, for papers by Maik Hauschild Breakdown of academic impact, for papers by Meghan Brennan Breakdown of academic impact, for papers by Charles E. Leonard Breakdown of academic impact, for papers by I. Raoust Breakdown of academic impact, for papers by Riccardo Giovanazzi Breakdown of academic impact, for papers by Emma J. Groen
Rankless by CCL
2026